| 000 | 01737 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516204626.0 | ||
| 264 | 0 | _c20150415 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1740-634X | ||
| 024 | 7 |
_a10.1038/npp.2014.79 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWaschkies, Conny F | |
| 245 | 0 | 0 |
_aNeuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cSep 2014 |
||
| 300 |
_a2331-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agents _xpharmacology |
| 650 | 0 | 4 |
_aGABA Agents _xpharmacology |
| 650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aProton Magnetic Resonance Spectroscopy _xmethods |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aBruns, Andreas | |
| 700 | 1 | _aMüller, Stephan | |
| 700 | 1 | _aKapps, Martin | |
| 700 | 1 | _aBorroni, Edilio | |
| 700 | 1 | _avon Kienlin, Markus | |
| 700 | 1 | _aRudin, Markus | |
| 700 | 1 | _aKünnecke, Basil | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 39 _gno. 10 _gp. 2331-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/npp.2014.79 _zAvailable from publisher's website |
| 999 |
_c23701449 _d23701449 |
||